Mesenchymal Stem Cells Showing Promise in Treating Diabetes

Published in Journal of Translational Medicine

A new review highlights the potential of mesenchymal stem cell (MSC) therapies for diabetes treatment, noting their ability to regulate the immune system, promote tissue regeneration, and improve metabolic function. Early-stage clinical trials show encouraging results, but optimizing delivery methods and ensuring consistent cell quality remain essential challenges before broader application.

Read the full article in Journal of Translational Medicine:

👉 The Promise of Cell-Based Therapies in Diabetes

Images used are for illustrative purposes only and do not depict actual persons, products, or facilities. For full detail, refer to the original article via the provided link.